Literature DB >> 1836197

Severe perinatal liver disease and Down syndrome: an apparent relationship.

E D Ruchelli1, A Uri, J E Dimmick, K E Bove, D S Huff, L M Duncan, J B Jennings, C L Witzleben.   

Abstract

Down syndrome (DS) is not usually thought of in association with significant infantile liver disease. We present clinical and histopathologic data from 10 patients with DS who presented with severe liver disease at birth or within the first few weeks of life, and summarize the findings of eight previously reported cases. The liver disease was fatal in all but one case. Diffuse lobular fibrosis surrounding proliferating ductular elements and residual hepatocytes characterized the pathologic findings in the liver in all patients. A large number of megakaryocytes were present in the liver in nine of 12 patients. The phenotype of "perinatal hemochromatosis" was documented in eight of nine cases in which the presence of iron was investigated. Since only a fraction of the patients with this phenotype have DS, the patients we describe seem to represent a relatively well-defined subset of the perinatal hemochromatosis phenotype. The existence of such a subset suggests that the perinatal hemochromatosis phenotype does not represent a single etiopathogenetic disorder. The association between DS, megakaryocytic infiltrates in the liver, and fatal subacute/chronic liver disease gives rise to the speculation that fibrosis-promoting factors and/or metabolic abnormalities, such as those resulting from a gene dosage effect, may play a role in the genesis of the liver disease, perhaps due to a particular susceptibility of fetal liver.

Entities:  

Mesh:

Year:  1991        PMID: 1836197     DOI: 10.1016/0046-8177(91)90111-2

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  Hematopoietic disorders in Down syndrome.

Authors:  John K Choi
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

2.  Hepatic failure, neonatal hemochromatosis and porto-pulmonary hypertension in a newborn with trisomy 21--a case report.

Authors:  Erin Neil; Josef Cortez; Aparna Joshi; Erawati V Bawle; Janet Poulik; Mark Zilberman; Mohammad F El-Baba; Beena G Sood
Journal:  Ital J Pediatr       Date:  2010-05-18       Impact factor: 2.638

Review 3.  Neonatal hemochromatosis.

Authors:  Amy G Feldman; Peter F Whitington
Journal:  J Clin Exp Hepatol       Date:  2013-11-27

4.  Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis.

Authors:  Myoung Ja Park; Manabu Sotomatsu; Kentaro Ohki; Kokoro Arai; Kenichi Maruyama; Tomio Kobayashi; Akira Nishi; Kiyoko Sameshima; Takeshi Takagi; Yasuhide Hayashi
Journal:  Int J Hematol       Date:  2013-12-14       Impact factor: 2.490

5.  Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism.

Authors:  A L Kelly; P W Lunt; F Rodrigues; P J Berry; D M Flynn; P J McKiernan; D A Kelly; G Mieli-Vergani; T M Cox
Journal:  J Med Genet       Date:  2001-09       Impact factor: 6.318

6.  Novel insights from fetal and placental phenotyping in 3 mouse models of Down syndrome.

Authors:  April D Adams; Victoria Hoffmann; Laura Koehly; Faycal Guedj; Diana W Bianchi
Journal:  Am J Obstet Gynecol       Date:  2021-03-22       Impact factor: 10.693

7.  De novo duplication of chromosome 16p in a female infant with signs of neonatal hemochromatosis.

Authors:  Eva Maria Christina Schwaibold; Iris Bartels; Helmut Küster; Michael Lorenz; Peter Burfeind; Ronja Adam; Barbara Zoll
Journal:  Mol Cytogenet       Date:  2014-01-23       Impact factor: 2.009

8.  Role of monocyte chemoattractant protein-1 in liver fibrosis with transient myeloproliferative disorder in down syndrome.

Authors:  Kenichiro Kobayashi; Takako Yoshioka; Jun Miyauchi; Atsuko Nakazawa; Nobutaka Kiyokawa; Toshiro Maihara; Ikuya Usami
Journal:  Hepatol Commun       Date:  2018-02-01

9.  Altered pro-inflammatory and anti-inflammatory plasma cytokines levels in children with Down's syndrome: A meta-analysis.

Authors:  Nitu Nigam; Prithvi K Singh; Neena Raizada; Balendra P Singh; Shalini Tripathi; Monica Agrawal; Harish Gupta; Sharad Singh; Ghizal Fatima; Sanjay K Nigam; Shailendra K Saxena
Journal:  J Family Med Prim Care       Date:  2021-11-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.